Market Overview:
The global gastrointestinal (GI) stent market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The GI stent market is segmented on the basis of type, application, and region. On the basis of type, the GI stent market is segmented into biliary stents, duodenal stents, colonic stents, pancreatic stents and esophageal Stents. Biliary diseases are one of the most common indications for a GI Stent placement. The growth in this indication can be attributed to an increase in incidence rates of biliary tract cancers and an aging population with comorbidities that predispose them to develop these conditions.
 Stent Industry Outlook.svg)
Product Definition:
A gastrointestinal (GI) stent is a wire mesh tube that is inserted into the digestive system to help keep the passage open. The stent may be used to relieve a blockage or for other purposes.
Biliary Stents:
Biliary stents are used to treat obstructions in the bile ducts. They are minimally invasive and have a low risk of infection & recurrence, high patient satisfaction, and reduced hospital stay.
Duodenal Stents:
Duodenal stents are used to treat conditions such as stomach ulcers, esophageal cancer, and gastric cardia diseases. The device consists of a flexible wire or a metal tube which is passed through the mouth into the upper digestive system and then comes out of the other end. It is inserted into areas where there is damage in lower gastrointestinal tract (gastrointestinal stent) caused by various factors such as radiation therapy, surgery or chronic disease.
Application Insights:
The market is segmented by application into biliary diseases, colorectal cancer, stomach cancer, and pancreatic cancer. The biliary diseases segment dominated the global gastro intestinal stent market in terms of revenue share in 2017 owing to the increasing prevalence of chronic liver disorders such as nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC), and fibrosis stage cirrhosis.
According to a study published by NCBI in 2018, NASH is estimated to affect around 60 million people across the globe with a significant increase anticipated during 2030s & 2040s. As per this same source, it has been estimated that NASH will become prevalent among middle-aged individuals at an alarming rate during 2030s & 2040s which would subsequently drive demand for GI stents over the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to a high prevalence of gastric cancer and presence of key players in this region. Moreover, increasing government funding for R&D activities pertaining to innovation of innovative stents is also expected to drive the regional market over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period due to rising incidence rates of stomach cancer and other diseases associated with digestive system. Increasing awareness regarding early diagnosis among people will drive regional demand further. In addition, growing medical tourism industry due to availability of advanced treatment procedures at affordable costs will boost demand further. Presence major companies such as Medtronic; Boston Scientific Corporation; Stryker Corporation; Zimmer Biomet Holdings, Inc.; BMS Medical Products LLC.
Growth Factors:
- Increasing incidence of gastrointestinal diseases: The increasing incidence of gastrointestinal diseases is one of the major growth drivers for the GI stent market. According to a study by the World Health Organization (WHO), approximately 9% of the global population suffers from some form of gastrointestinal disease. This number is expected to increase in the coming years due to factors such as changing lifestyles, unhealthy diets, and increasing pollution levels.
- Rising demand for minimally invasive procedures: The growing demand for minimally invasive procedures is another key driver for the GI stent market. Minimally invasive procedures are less traumatic and result in shorter recovery times as compared to traditional surgery techniques. As a result, they are becoming increasingly popular among patients worldwide.
- Technological advancements: The development of new and innovative technologies has been a key driver for the GI stent market over the past few years. These technologies have helped improve patient outcomes and reduce complications associated with these devices. For instance, recent advancements in drug-eluting technology have helped reduce restenosis rates after implantation significantly compared to older generations of devices without this technology incorporated into them..
Scope Of The Report
Report Attributes
Report Details
Report Title
Gastrointestinal (GI) Stent Market Research Report
By Type
Biliary Stents, Duodenal Stents, Colonic Stents, Pancreatic Stents, Esophageal Stents
By Application
Biliary Disease, Colorectal Cancer, Stomach Cancer
By Companies
Boston Scientific, Cook Medical, ELLA-CS, ConMed, Gore Medical, Taewoong Medical, Hobbs Medical, C.R. Bard, Merit Endotek, Olympus America, Boston Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
195
Number of Tables & Figures
137
Customization Available
Yes, the report can be customized as per your need.
Global Gastrointestinal (GI) Stent Market Report Segments:
The global Gastrointestinal (GI) Stent market is segmented on the basis of:
Types
Biliary Stents, Duodenal Stents, Colonic Stents, Pancreatic Stents, Esophageal Stents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biliary Disease, Colorectal Cancer, Stomach Cancer
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Cook Medical
- ELLA-CS
- ConMed
- Gore Medical
- Taewoong Medical
- Hobbs Medical
- C.R. Bard
- Merit Endotek
- Olympus America
- Boston Scientific
 Stent Market Overview.svg)
Highlights of The Gastrointestinal (GI) Stent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biliary Stents
- Duodenal Stents
- Colonic Stents
- Pancreatic Stents
- Esophageal Stents
- By Application:
- Biliary Disease
- Colorectal Cancer
- Stomach Cancer
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gastrointestinal (GI) Stent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Stent Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A gastroenterologist-placed GI stent is a small, metal tube that is inserted through the stomach and into the intestines to help keep the intestine open. This can be helpful in preventing blockages from forming in the intestine, which can lead to complications such as infection and malnutrition.
Some of the major companies in the gastrointestinal (gi) stent market are Boston Scientific, Cook Medical, ELLA-CS, ConMed, Gore Medical, Taewoong Medical, Hobbs Medical, C.R. Bard, Merit Endotek, Olympus America, Boston Scientific.
The gastrointestinal (gi) stent market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gastrointestinal (GI) Stent Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gastrointestinal (GI) Stent Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gastrointestinal (GI) Stent Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gastrointestinal (GI) Stent Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gastrointestinal (GI) Stent Market Size & Forecast, 2018-2028
4.5.1 Gastrointestinal (GI) Stent Market Size and Y-o-Y Growth
4.5.2 Gastrointestinal (GI) Stent Market Absolute $ Opportunity
Chapter 5 Global Gastrointestinal (GI) Stent Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Gastrointestinal (GI) Stent Market Size Forecast by Type
5.2.1 Biliary Stents
5.2.2 Duodenal Stents
5.2.3 Colonic Stents
5.2.4 Pancreatic Stents
5.2.5 Esophageal Stents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Gastrointestinal (GI) Stent Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Gastrointestinal (GI) Stent Market Size Forecast by Applications
6.2.1 Biliary Disease
6.2.2 Colorectal Cancer
6.2.3 Stomach Cancer
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gastrointestinal (GI) Stent Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gastrointestinal (GI) Stent Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Gastrointestinal (GI) Stent Analysis and Forecast
9.1 Introduction
9.2 North America Gastrointestinal (GI) Stent Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Gastrointestinal (GI) Stent Market Size Forecast by Type
9.6.1 Biliary Stents
9.6.2 Duodenal Stents
9.6.3 Colonic Stents
9.6.4 Pancreatic Stents
9.6.5 Esophageal Stents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Gastrointestinal (GI) Stent Market Size Forecast by Applications
9.10.1 Biliary Disease
9.10.2 Colorectal Cancer
9.10.3 Stomach Cancer
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Gastrointestinal (GI) Stent Analysis and Forecast
10.1 Introduction
10.2 Europe Gastrointestinal (GI) Stent Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Gastrointestinal (GI) Stent Market Size Forecast by Type
10.6.1 Biliary Stents
10.6.2 Duodenal Stents
10.6.3 Colonic Stents
10.6.4 Pancreatic Stents
10.6.5 Esophageal Stents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Gastrointestinal (GI) Stent Market Size Forecast by Applications
10.10.1 Biliary Disease
10.10.2 Colorectal Cancer
10.10.3 Stomach Cancer
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Gastrointestinal (GI) Stent Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Gastrointestinal (GI) Stent Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Gastrointestinal (GI) Stent Market Size Forecast by Type
11.6.1 Biliary Stents
11.6.2 Duodenal Stents
11.6.3 Colonic Stents
11.6.4 Pancreatic Stents
11.6.5 Esophageal Stents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Gastrointestinal (GI) Stent Market Size Forecast by Applications
11.10.1 Biliary Disease
11.10.2 Colorectal Cancer
11.10.3 Stomach Cancer
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Gastrointestinal (GI) Stent Analysis and Forecast
12.1 Introduction
12.2 Latin America Gastrointestinal (GI) Stent Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Gastrointestinal (GI) Stent Market Size Forecast by Type
12.6.1 Biliary Stents
12.6.2 Duodenal Stents
12.6.3 Colonic Stents
12.6.4 Pancreatic Stents
12.6.5 Esophageal Stents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Gastrointestinal (GI) Stent Market Size Forecast by Applications
12.10.1 Biliary Disease
12.10.2 Colorectal Cancer
12.10.3 Stomach Cancer
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Gastrointestinal (GI) Stent Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Gastrointestinal (GI) Stent Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Gastrointestinal (GI) Stent Market Size Forecast by Type
13.6.1 Biliary Stents
13.6.2 Duodenal Stents
13.6.3 Colonic Stents
13.6.4 Pancreatic Stents
13.6.5 Esophageal Stents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Gastrointestinal (GI) Stent Market Size Forecast by Applications
13.10.1 Biliary Disease
13.10.2 Colorectal Cancer
13.10.3 Stomach Cancer
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gastrointestinal (GI) Stent Market: Competitive Dashboard
14.2 Global Gastrointestinal (GI) Stent Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 Cook Medical
14.3.3 ELLA-CS
14.3.4 ConMed
14.3.5 Gore Medical
14.3.6 Taewoong Medical
14.3.7 Hobbs Medical
14.3.8 C.R. Bard
14.3.9 Merit Endotek
14.3.10 Olympus America
14.3.11 Boston Scientific
